Tag: science
-
How Etentamig Redirects T Cells in Multiple Myeloma
Etentamig is a BCMA × CD3 bispecific T-cell engager designed with bivalent BCMA binding, low-affinity CD3 engagement and retained FcRn binding to redirect T cells against multiple myeloma cells.
-
Three Different Ways to Reduce Phototoxic Pain in EPP and XLP
Dersimelagon, Scenesse and bitopertin approach phototoxic pain through fundamentally different strategies. This BP Science explainer compares MC1R-driven photoprotection with upstream reduction of protoporphyrin IX (PPIX) production in erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP).
-
Eli Lilly Strikes $475 M Gene Therapy Deal with MeiraGTx for Rare Retinal Disease
Eli Lilly’s $475 million acquisition of MeiraGTx marks a bold step into next-generation gene therapies targeting rare retinal diseases. Despite challenges in the gene therapy market, the move reflects growing optimism about using advanced genetic tools to improve the lives of patients with rare inherited disorders.